Treatment Response in Patients With Medication-Overuse Headache

Sponsor
Sultan 1. Murat State Hospital
Study ID
NCT07487649
Status
Recruiting
Apply to this trial

Conditions

  • Greater Occipital Nerve Block
  • Headache
  • Medication-overuse Headache
  • Treatment

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Treatment outcome — OTHER
    Before the injection, patients will be evaluated for the number of headache days, headache severity, the number of days of analgesic use for headache, headache-related disability, pressure pain threshold over the bilateral greater occipital nerve, anxiety and depression scores, and sleep quality. At 1 and 2 months after the injection, they will be reassessed for the number of headache days, headache severity, and the number of days of analgesic use for headache. In addition, at 1 hour after the injection, the pain experienced during the injection procedure will be assessed.

Study Details

The aim of this study to evaluate pre-injection patient-related factors that may influence treatment response in patients with medication-overuse headache who underwent ultrasound-guided greater occipital nerve block.

Key Dates

First listed
Mar 23, 2026
Start date
Mar 17, 2026
Status verified
Mar 2026
Primary completion
May 30, 2026
Completion
May 30, 2026

Study Design

Enrollment
70 participants (estimated)

Arms

  • Arm: Treatment success group
    Patients who demonstrated a ≥50% reduction in the number of days of analgesic use for headache at the end of the second-month evaluation
  • Arm: Treatment failure group
    Patients who demonstrated a \<50% reduction in the number of days of analgesic use for headache at the end of the second-month evaluation

Primary Outcome Measure

the number of days of analgesic use for headache [ Time Frame: Baseline ]

Central Contacts

Related Studies